Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» Details

Guru Trades

Q2 2016

XBI Guru Trades in Q2 2016

Steven Cohen 191,000 sh (New)
First Eagle Investment 18,150 sh (unchged)
» More
Q3 2016

XBI Guru Trades in Q3 2016

Louis Moore Bacon 100,000 sh (unchged)
First Eagle Investment Sold Out
Steven Cohen 152,500 sh (-20.16%)
» More
Q4 2016

XBI Guru Trades in Q4 2016

Paul Tudor Jones 325,000 sh (New)
Steven Cohen 63,500 sh (-58.36%)
» More
Q1 2017

XBI Guru Trades in Q1 2017

Louis Moore Bacon 300,000 sh (New)
Steven Cohen 500,000 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
» More


PB Ratio 5.63
XBI's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 5.63 )
Ranked among companies with meaningful PB Ratio only.
XBI' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 5.68
Current: 5.63

Dividend & Buy Back

Dividend Yield % 0.17
XBI's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.17 )
Ranked among companies with meaningful Dividend Yield % only.
XBI' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.17
Current: 0.17
5-Year Yield-on-Cost % 0.17
XBI's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.17 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
XBI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.17
Current: 0.17

More Statistics

Short Percentage of Float0.00%
52-Week Range $49.68 - 72.32
Shares Outstanding (Mil)44,000,000.00
» More Articles for XBI


Articles On GuruFocus.com
AT&T Invests Nearly $675 Million Over 3-Year Period to Enhance Local Networks in Nevada May 25 2017 
/C O R R E C T I O N -- Stoneridge, Inc./ May 25 2017 
Johnson & Johnson to Participate in the Goldman Sachs 38th Annual Global Healthcare Conference May 25 2017 
Simmons First National Corporation Declares $0.25 Per Share Dividend May 25 2017 
Lamar Advertising Company Announces Cash Dividend on Common Stock May 25 2017 
Territorial Bancorp Inc. Announces Results of Annual Meeting May 25 2017 
The Radio City Rockettes Join Forces With the USO to Support Service Members and Their Families From May 25 2017 
Georgia Power hosts 2017 Paperless Billing Giveaway May 25 2017 
Sono-Tek Announces Fiscal Year 2017 Results and First Quarter 2018 Guidance May 25 2017 
Coach Names James Franco As The Face Of New Men's Fragrance May 25 2017 

More From Other Websites
ETF Flyer: Trail Mix of 'Tech' Stocks May 18 2017
Are Stock Returns during Summer Months That Bad? May 18 2017
The Latest Market Trends Every Biopharma Investor Needs to Know May 17 2017
Why Biotech Stocks Are Hitting the Skids May 15 2017
Alexion Pharmaceuticals Has Raised Its 2017 Earnings Guidance May 11 2017
ETF Flopper: Biotechnology and Pharmaceuticals Feel the Pain May 08 2017
Biotech ETF Rides Industry's Recovery May 05 2017
ETF Flopper: Biotech Bungle May 05 2017
A Biotech Warning Sign? May 04 2017
What to Do With These Strong ETFs May 04 2017
[$$] Four Small Biotechs See Bullish April Stock Buys May 03 2017
This Biotech ETF Has 'Bullish Potential' May 02 2017
Understanding Exelixis’s Operating Expense Expectations for 1Q17 Apr 26 2017
Should You Worry About A Trump Trap? Apr 25 2017
Biogen's Excellent Q1 Bodes Well for Biotech Apr 25 2017
Trump's First 100 Days: Is the "Trump Trade" Already Dead? Apr 24 2017
Why biotech stocks are a healthy bet in a sickly broader market Apr 20 2017
Biotech ETFs To Consider Ahead of Earnings Season Apr 12 2017
The Larger Aims of Obamacare: An Overview Apr 11 2017
These 2 Charts Show Just How Close We Are to Healthcare Collapse Apr 03 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)